PROM1 and neoplasm: The strong positive CD133-stained cells were counted, and 5.46% and 4.94% of total tumor cells were calculated in the untreated group and hesperidin-treated group, whereas the proportions were 6.89% in the gallic acid-treated group and 2.79% in the combination-treated group (Figure 6J).